Cargando…

Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases

The central nervous system is characterized by a high content of sphingolipids and by a high diversity in terms of different structures. Stage- and cell-specific sphingolipid metabolism and expression are crucial for brain development and maintenance toward adult age. On the other hand, deep dysregu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grassi, Sara, Mauri, Laura, Prioni, Simona, Cabitta, Livia, Sonnino, Sandro, Prinetti, Alessandro, Giussani, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689979/ https://www.ncbi.nlm.nih.gov/pubmed/31427962 http://dx.doi.org/10.3389/fphar.2019.00807

Ejemplares similares

Identification of the antigen recognized by rHIgM22, a remyelination-promoting human monoclonal antibody
por: Grassi, Sara, et al.
Publicado: (2015)

Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease
por: Di Pardo, Alba, et al.
Publicado: (2017)

Glycohydrolases in the central nervous system: the role of GBA2 in the neuronal differentiation
por: Samarani, Maura, et al.
Publicado: (2015)

Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System
por: Cannavo, Alessandro, et al.
Publicado: (2017)

Lipids and Membrane Lateral Organization
por: Sonnino, Sandro, et al.
Publicado: (2010)

Author Correction: Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease
por: Di Pardo, Alba, et al.
Publicado: (2018)

Commentary: The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertension
por: Bhavanam, Naga P., et al.
Publicado: (2015)

Ceramide and Sphingosine-1-Phosphate in Neurodegenerative Disorders and Their Potential Involvement in Therapy
por: Tringali, Cristina, et al.
Publicado: (2022)

Sphingosine 1-Phosphate Signaling as a Target in Hepatic Fibrosis Therapy
por: González-Fernández, Bárbara, et al.
Publicado: (2017)

Characterization and Expression of Sphingosine 1-Phosphate Receptors in Human and Rat Heart
por: Ahmed, Naseer, et al.
Publicado: (2017)

Extracellular Sphingosine-1-Phosphate Downstream of EGFR Increases Human Glioblastoma Cell Survival
por: Bassi, Rosaria, et al.
Publicado: (2021)

Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential Risks
por: Blankenbach, Kira V., et al.
Publicado: (2016)

Massive Accumulation of Sphingomyelin Affects the Lysosomal and Mitochondria Compartments and Promotes Apoptosis in Niemann-Pick Disease Type A
por: Carsana, Emma Veronica, et al.
Publicado: (2022)

The Role of Sphingolipids in Cancer Immunotherapy
por: Giussani, Paola, et al.
Publicado: (2021)

Selectivity and Specificity of Sphingosine 1-Phosphate Receptor Ligands: “Off-Targets” or Complex Pharmacology?
por: Pyne, Nigel J., et al.
Publicado: (2011)

Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis?
por: Vestri, Ambra, et al.
Publicado: (2017)

Activated platelets release sphingosine 1-phosphate and induce hypersensitivity to noxious heat stimuli in vivo
por: Weth, Daniela, et al.
Publicado: (2015)

Competitive Binding of Ozanimod and Other Sphingosine 1-Phosphate Receptor Modulators at Receptor Subtypes 1 and 5
por: Selkirk, Julie V., et al.
Publicado: (2022)

Selectivity and Specificity of Sphingosine-1-Phosphate Receptor Ligands: Caveats and Critical Thinking in Characterizing Receptor-Mediated Effects
por: Salomone, Salvatore, et al.
Publicado: (2011)

Extracellular Sphingosine-1-Phosphate: A Novel Actor in Human Glioblastoma Stem Cell Survival
por: Riccitelli, Elena, et al.
Publicado: (2013)

Sphingosine 1-Phosphate Receptor Modulator Fingolimod (FTY720) Attenuates Myocardial Fibrosis in Post-heterotopic Heart Transplantation
por: Ahmed, Naseer, et al.
Publicado: (2017)

Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets
por: Pelaia, Corrado, et al.
Publicado: (2022)

Interaction of microRNAs with sphingosine kinases, sphingosine-1 phosphate, and sphingosine-1 phosphate receptors in cancer
por: Xu, Guangmeng, et al.
Publicado: (2021)

Sphingosine 1-phosphate Stimulates Insulin Secretion and Improves Cell Survival by Blocking Voltage-dependent K(+) Channels in β Cells
por: Liu, Zhihong, et al.
Publicado: (2021)

Cardioprotective Effects of Sphingosine-1-Phosphate Receptor Immunomodulator FTY720 in a Clinically Relevant Model of Cardioplegic Arrest and Cardiopulmonary Bypass
por: Ahmed, Naseer, et al.
Publicado: (2019)

Sphingosine-1-Phosphate Receptor Subtype 1 (S1P1) Modulator IMMH001 Regulates Adjuvant- and Collagen-Induced Arthritis
por: Jin, Jing, et al.
Publicado: (2019)

Non-Mitogenic Fibroblast Growth Factor 1 Enhanced Angiogenesis Following Ischemic Stroke by Regulating the Sphingosine-1-Phosphate 1 Pathway
por: Zou, Yuchi, et al.
Publicado: (2020)

Probabilistic Pocket Druggability Prediction via One-Class Learning
por: Aguti, Riccardo, et al.
Publicado: (2022)

Sphingolipids and Atherosclerosis: The Dual Role of Ceramide and Sphingosine-1-Phosphate
por: Piccoli, Marco, et al.
Publicado: (2023)

The Role of Sphingolipids and Sphingosine-1-phosphate—Sphingosine-1-phosphate-receptor Signaling in Psoriasis
por: Masuda-Kuroki, Kana, et al.
Publicado: (2023)

Discovery of Leishmania Druggable Serine Proteases by Activity-Based Protein Profiling
por: Porta, Exequiel O. J., et al.
Publicado: (2022)

Sphingosine 1-Phosphate and Atherosclerosis
por: Kurano, Makoto, et al.
Publicado: (2018)

Exploring the druggability of the binding site of aurovertin, an exogenous allosteric inhibitor of F(O)F(1)-ATP synthase
por: Cofas-Vargas, Luis Fernando, et al.
Publicado: (2022)

Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis
por: Le Stunff, Hervé, et al.
Publicado: (2002)

A Glimpse of the Structural Biology of the Metabolism of Sphingosine-1-Phosphate
por: Ren, Ruobing, et al.
Publicado: (2021)

Promising Druggable Target in Head and Neck Squamous Cell Carcinoma: Wnt Signaling
por: Aminuddin, Amnani, et al.
Publicado: (2016)

Hippocampal Hyperactivity as a Druggable Circuit-Level Origin of Aberrant Salience in Schizophrenia
por: Kätzel, Dennis, et al.
Publicado: (2020)

Revisiting the neuroinflammation hypothesis in Alzheimer’s disease: a focus on the druggability of current targets
por: Wong-Guerra, Maylin, et al.
Publicado: (2023)

Sphingosine 1-Phosphate-Induced ICAM-1 Expression via NADPH Oxidase/ROS-Dependent NF-κB Cascade on Human Pulmonary Alveolar Epithelial Cells
por: Lin, Chih-Chung, et al.
Publicado: (2016)

Sphingosine Kinase 1 and Sphingosine-1-Phosphate Signaling in Colorectal Cancer
por: Bao, Yonghua, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kesoeaae89pp7qme9h05evcbfg